Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024

ObjectiveTo investigate which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment by using the FDA Adverse Event Reporting System (FAERS) database.MethodsWe selected data from the first quarter (Q1) of 2013 to the second quarter (Q4) of 2024 from the FDA FAERS database...

Full description

Saved in:
Bibliographic Details
Main Authors: Sheng Wei, Changping He, Xiangping Xie, Anping Zhang, Simin Tang, Sha Li, Yanlang He
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1491921/full
Tags: Add Tag
No Tags, Be the first to tag this record!